Compare iShares Russell 2000 ETF (IWM) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Russell 2000 ETF vs 22nd Century Group Inc — how do they compare? iShares Russell 2000 ETF trades at $293.72, while 22nd Century Group Inc trades at $4.26 (market cap $1.56M). The key difference: iShares Russell 2000 ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| IWM | XXII | |
|---|---|---|
52-Week High | $300.45 | $999.00 |
52-Week Low | $214.95 | $3.90 |
Market Cap | — | $1.56M |
Sector | — | Technology |
Enterprise Value | — | -$6.67M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IWM, tracking the Russell 2000 small-cap index, trades at $292.34, down 0.6% on the day. Technical indicators show a bullish bias with moving averages supporting an uptrend, while oscillators are neutral. Recent news highlights strong small-cap outperformance, with the Russell 2000 up approximately 20% year-to-date, fueled by institutional inflows and a shifting interest rate outlook.
The outlook for IWM is positive, driven by potential for continued small-cap leadership amid economic expansion and lower rate expectations. Key risks include higher volatility relative to large-caps and sensitivity to broader economic conditions. The ETF offers diversified exposure to nearly 2,000 small-cap stocks, but investors should weigh its 0.19% expense ratio against alternatives.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
